Co-morbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 11, Issue 4, 2014, Pages 388-400

  Budweiser, Stephan ^a,b   Harlacher, Martina ^b   Pfeifer, Michael ^a,b   Jörres, Rudolf A ^c  

^a RoMed Clinic Rosenheim   (Germany)

^b Donaustauf Hospital   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Co morbidity score; Long term survival; Prognostic factors; Residual volume

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RESIDUAL VOLUME; RISK FACTOR; SURVIVAL; TOTAL LUNG CAPACITY; AGE; BODY MASS; COMPLICATION; DYSPNEA; HYPERLIPIDEMIAS; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

AGE FACTORS; AGED; BODY MASS INDEX; COMORBIDITY; DIABETES MELLITUS; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDUAL VOLUME; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TOTAL LUNG CAPACITY;

EID: 84904205515     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2013.836174     Document Type: Article

References (56)

1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370:765-73.
2. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20.
3. Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of survival in COPD: more than just the FEV1. Respir Med 2008; 102 Suppl 1:S27-35.
4. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347-365.
5. Celli BR, Cote CG, Marin JM, Casanova C, Montes Oca M de, Mendez RA, et al. The body-mass index, airfl ow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005-1012.
6. Puhan MA, Garcia-Aymerich J, Frey M, ter Riet G, Anto JM, Agusti AG, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009; 374:704-711.
7. Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009; 180:1189-1195.
8. Casanova C, Cote C, Torres JP de, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171:591-597.
9. Budweiser S, Jorres RA, Riedl T, Heinemann F, Hitzl AP, Windisch W, et al. Predictors of survival in COPD patients with chronic hypercapnic respiratory failure receiving noninvasive home ventilation. Chest 2007; 131:1650-1658.
10. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F. Co-morbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2011; 17 Suppl 1:S21-28.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
12. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, et al. Co-morbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 2012; 142:1126-1133.
13. Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and co-morbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27:689-696.
14. Terzano C, Conti V, Di Stefano F, Petroianni A, Ceccarelli D, Graziani E, et al. Co-morbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung 2010; 188:321-329.
15. Antonelli Incalzi R, Fuso L, Rosa M de, Forastiere F, Rapiti E, Nardecchia B, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10:2794-800.
16. Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124:459-467.
17. Divo M, Cote C, Torres JP de, Casanova C, Marin JM, Pinto-Plata V, et al. Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:155-161.
18. Celli BR. Predictors of mortality in COPD. Respir Med 2010; 104:773-779.
19. Mannino DM, Th orn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32:962-969.
20. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined co-morbidity index. J Clin Epidemiol 1994; 47:1245-1251.
21. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988; 93:580-586.
22. American Th oracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995; 152:1107-1136.
23. Sterk PJ, Fabbri LM, Quanjer PH, Cockcroft DW, O'Byrne PM, Anderson SD, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offi cial Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16:53-83.
24. American Th oracic Society (ATS) statement. Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117.
25. Enright PL, Sherrill DL. Reference equations for the sixminute walk in healthy adults. Am J Respir Crit Care Med 1998; 158:1384-1387.
26. Keaney NP, Ansari K, Munby J, Price M, Kay A, Taylor IK. P219 Ten year mortality in a primary care COPD cohort: multidimensional index BOD more discriminant than GOLD staging. Thorax 2011; 66:A157.
27. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular fi ltration rate. Ann Intern Med 2009; 150:604-612.
28. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specifi c mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62:411-415.
29. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classifi cation: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81.
30. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003; 163:1475-1480.
31. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006; 28:1245-1257.
32. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29:923-929.
33. Kollert F, Tippelt A, Muller C, Jorres RA, Porzelius C, Pfeifer M et al. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2013;58(7):1204-1212.
34. Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, et al. Infl ammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1065-1072.
35. Chailleux E, Laaban J, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 2003; 123:1460-1466.
36. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856-1861.
37. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classifi cation of lung disease and mortality: fi ndings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100:115-122.
38. Almagro P, Calbo E, Ochoa Echaguen A de, Barreiro B, Quintana S, Heredia JL, et al. Mortality after hospitalization for COPD. Chest 2002; 121:1441-1448.
39. Laurin C, Lavoie KL, Bacon SL, Dupuis G, Lacoste G, Cartier A, et al. Sex diff erences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest 2007; 132:148-155.
40. van Manen JG, Bindels PJE, Dekker FW, IJzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57:412-416.
41. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fi brillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21:1012-1016.
42. Ng T, Niti M, Tan W, Cao Z, Ong K, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: eff ect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167:60-67.
43. Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012; 67:970-976.
44. Voogd JN de, Wempe JB, Koeter GH, Postema K, van Sonderen E, Ranchor AV, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135:619-625.
45. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V. Chronic renal failure: a neglected co-morbidity of COPD. Chest 2010; 137:831-837.
46. Marin JM, Alfageme I, Almagro P, Casanova C, Esteban C, Soler-Cataluna JJ, et al. Multicomponent indices to predict survival in COPD: The COllaborative COhorts to assess multicomponent indices of COPD in Spain-COCOMICS study. Eur Respir J 2013;42(2):323-332.
47. Lahaije AJMC, van Helvoort HAC, Dekhuijzen PNR, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinfl ation explain physical inactivity in COPD better than FEV1. Respir Med 2013; 107:834-840.
48. Vassaux C, Torre-Bouscoulet L, Zeineldine S, Cortopassi F, Paz-Diaz H, Celli BR, et al. Eff ects of hyperinfl ation on the oxygen pulse as a marker of cardiac performance in COPD. Eur Respir J 2008; 32:1275-1282.
49. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoff man EA, et al. Percent emphysema, airfl ow obstruction, and impaired left ventricular fi lling. N Engl J Med 2010; 362:217-227.
50. Watz H, Waschki B, Meyer T, Kretschmar G, Kirsten A, Claussen M, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinfl ation. Chest 2010; 138:32-38.
51. O'Donnell DE, Laveneziana P. The clinical importance of dynamic lung hyperinfl ation in COPD. COPD 2006; 3:219-232.
52. Waschki B, Kirsten A, Holz O, Muller K, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140:331-342.
53. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volumereduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059-2073.
54. Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoff man E, et al. Pulmonary hyperinfl ation and left ventricular mass: The multi-ethnic study of atherosclerosis COPD study. Circulation 2013; 127:1503-1511.
55. Antonelli-Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, et al. Drawing impairment predicts mortality in severe COPD. Chest 2006; 130:1687-1694.
56. Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic fi ndings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1982; 142:1470-1476.